Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 9.2B | 9.7B | 8.7B | 7.7B |
Cost of revenue | 5.2B | 5.6B | 5.0B | 4.7B |
Gross profit | 4.0B | 4.2B | 3.7B | 3.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.2B | 2.6B | 2.3B | 1.9B |
Operating income | 1.2B | 1.0B | 872.2M | 409.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 284.3M | 274.2M | 250.9M | 448.3M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 801.1M | 641.4M | -14.2M |
Tax provision | 273.1M | 226.5M | 165.8M | 9.9M |
Net income | 786.2M | 574.7M | 475.6M | -24.1M |
Basic EPS | — | 2.1 | 1.7 | — |
Diluted EPS | — | 2.1 | 1.7 | — |
Basic average shares | — | 280.3M | 279.8M | — |
Diluted average shares | — | 280.3M | 279.8M | — |
EBITDA | 1.5B | 1.2B | 1.1B | 621.9M |
Net income from continuing op. | — | — | — | — |
Minority interests | 184K | 0 | — | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |